| Title |
Author |
Type |
Date |
Words |
| Naperville Park District to dedicate Chuck Papanos Honorary Garden July 30. |
Submitted by Naperville Park District |
|
Jul 25, 2021 |
216 |
| Honoring a can-do man. |
Lauren Rohr lrohr@dailyherald.com |
|
Jul 24, 2021 |
549 |
| Eight-weeks between first and second Pfizer vaccine doses the 'sweet spot' for fighting Delta variant; 'The decision to put it to eight weeks is really balancing all the wider issues, the pros and cons'. |
By, Lucy John |
|
Jul 23, 2021 |
754 |
| Anocca announces USD47m from Series B Financing. |
|
|
Jul 22, 2021 |
186 |
| Anocca announces USD47m from Series B Financing. |
|
|
Jul 22, 2021 |
187 |
| Anocca announces USD47m from Series B Financing. |
|
|
Jul 22, 2021 |
188 |
| Eureka Therapeutics Initiates Phase I/II ARYA-3 Clinical Trial of GPC3 Targeting ARTEMIS T Cell Therapy in Liver Cancer. |
|
|
Jul 22, 2021 |
422 |
| TScan Therapeutics to present discovery of T cell targets for COVID-19. |
|
|
Jul 21, 2021 |
205 |
| Merus announces publication on MCLA-145's mechanism of action. |
|
|
Jul 21, 2021 |
232 |
| Single Institutional Experience on Orbital Inflammatory Pseudotumor: Diagnostic and Management Challenge. |
Derakhshandeh, Roshanak; Dimopoulos, Yiannis Petros; Goodglick, Todd Alan; Chanine, Joeffrey; Sabet, |
Clinical report |
Jul 21, 2021 |
3121 |
| Laboratory Infectolab Americas Releases COVID-19 T-cell Test. |
|
|
Jul 20, 2021 |
367 |
| I Came When Music Was More Of Passion Than Money - Late Sound Sultan. |
|
|
Jul 17, 2021 |
873 |
| Adicet Bio announces formation of Scientifc Advisory Board. |
|
|
Jul 15, 2021 |
213 |
| Rubius Therapeutics announces publication of RTX-240 preclinical data. |
|
|
Jul 15, 2021 |
204 |
| ImmunityBio Authorized to Proceed with Phase 1/2/3 Randomized Trial in South Africa of Their Dual-Antigen T-Cell Vaccine as a Universal Boost in Previously Vaccinated Participants Against COVID-19. |
|
|
Jul 15, 2021 |
759 |
| iBio reports successful preclinical studies with COVID vaccine candidate. |
|
|
Jul 15, 2021 |
261 |
| Artax Biopharma receives UK authorisation for AX-158 Phase one clinical trial. |
|
|
Jul 14, 2021 |
155 |
| Artax Biopharma receives UK authorisation for AX-158 Phase one clinical trial. |
|
|
Jul 14, 2021 |
156 |
| ImmunityBio gets OK from South Africa for dual-antigen T-cell for Covid booster. |
|
|
Jul 14, 2021 |
300 |
| First Patient Dosed in Phase 1 Clinical Trial Evaluating CB-010, a CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy, in Patients with Relapsed or Refractory B Cell Non-Hodgkin Lymphoma. |
|
|
Jul 14, 2021 |
607 |
| J&J says COVID shot shows neutralizing antibody activity against Delta variant. |
|
|
Jul 14, 2021 |
209 |
| NBBF Dedicates D'Tigers Victories Over US, Argentina To Sound Sultan. |
|
|
Jul 13, 2021 |
256 |
| Tevogen Bio wins FDA clearance of IND Application for TVGN-489 for COVID-19. |
|
|
Jul 13, 2021 |
232 |
| Tevogen Bio wins FDA clearance of IND Application for TVGN-489 for COVID-19. |
|
|
Jul 13, 2021 |
231 |
| Lava Therapeutics announces treatment of first patient in Phase 1/2a of LAVA-051. |
|
|
Jul 13, 2021 |
306 |
| Genocea doses first patient in Phase 1/2a TiTAN clinical trial for GEN-011. |
|
|
Jul 13, 2021 |
166 |
| 'He Lived An Exemplary Life,' President Buhari Lauds Sound Sultan. |
|
|
Jul 12, 2021 |
228 |
| Sound Sultan Buried Amidst Tears, Encomiums. |
|
Obituary |
Jul 12, 2021 |
332 |
| Kymera Therapeutics presents new preclinical data on STAT3 degraders. |
|
|
Jul 12, 2021 |
233 |
| Nigeria loses Sound Sultan, ace musician, actor and rapper, to cancer. |
|
|
Jul 11, 2021 |
490 |
| Eurofins Viracor unveils the SARS-CoV-2 inSIGHT T Cell immunity testing tool. |
|
|
Jul 9, 2021 |
216 |
| Eurofins Viracor unveils the SARS-CoV-2 inSIGHT T Cell immunity testing tool. |
|
|
Jul 9, 2021 |
215 |
| Eurofins Viracor Launches Coronavirus SARS-CoV-2 inSIGHT T Cell Immunity Testing. |
|
|
Jul 9, 2021 |
349 |
| 4D pharma publishes research showing LBP MRx1299 improving the activity of CAR-T. |
|
|
Jul 6, 2021 |
185 |
| Achilles Therapeutics enroll first patient in ongoing Phase I/IIa study in NSCLC. |
|
|
Jul 1, 2021 |
279 |
| SenlangBio initiates first-in-human trial in recurrent brain cancer. |
|
|
Jul 1, 2021 |
268 |
| Shiitake Mushrooms Boost Immunity. |
|
|
Jul 1, 2021 |
190 |
| Athersys announces publication of research data on MAPC. |
|
|
Jun 30, 2021 |
260 |
| Cullinan receives FDA clearance of IND application for CLN-619. |
|
|
Jun 29, 2021 |
180 |
| Vaccibody to trial two new SARS CoV-2 virus DNA vaccine candidates. |
|
|
Jun 29, 2021 |
203 |
| Vaccibody to trial two new SARS CoV-2 virus DNA vaccine candidates. |
|
|
Jun 29, 2021 |
202 |
| Vaccibody to trial two new SARS CoV-2 virus DNA vaccine candidates. |
|
|
Jun 29, 2021 |
201 |
| Precision BioSciences, SpringsWorks dose 1st patient in PBCAR269A trial. |
|
|
Jun 28, 2021 |
266 |
| Sana's data shows survival of transplanted stem cells without immunosuppression. |
|
|
Jun 27, 2021 |
277 |
| Bristol Myers Squibb Receives Positive CHMP Opinion for Anti-BCMA CAR T Cell Therapy Abecma for Relapsed and Refractory Multiple Myeloma. |
|
|
Jun 25, 2021 |
386 |
| CellPoint signs contract with Lonza's Personalized Medicine Business Unit. |
|
|
Jun 24, 2021 |
159 |
| CellPoint signs contract with Lonza's Personalized Medicine Business Unit. |
|
|
Jun 24, 2021 |
158 |
| VBI Vaccines,Brii Bio present data on BRII-179 study for hepatitis B. |
|
|
Jun 23, 2021 |
266 |
| Blackstone commits $250M toward new CAR-T company with Intellia Therapeutics. |
|
|
Jun 22, 2021 |
332 |
| C4 Therapeutics presents preclinical data on CFT7455. |
|
|
Jun 21, 2021 |
392 |
| Auris Medical announces puvlication of results from study with OligoPhore. |
|
|
Jun 21, 2021 |
341 |
| NextCure announces publication of NC410 preclinical data. |
|
|
Jun 21, 2021 |
176 |
| Harbour BioMed signs collaboration agreement with Dana-Farber Cancer Institute. |
|
|
Jun 16, 2021 |
166 |
| Harbour BioMed signs collaboration agreement with Dana-Farber Cancer Institute. |
|
|
Jun 16, 2021 |
167 |
| C4 Therapeutics first patient dosed in phase 1/2 clinical trial on CFT7455. |
|
|
Jun 14, 2021 |
238 |
| Mustang Bio reports updated interim Phase 1/2 data for MB-106. |
|
|
Jun 11, 2021 |
268 |
| Equillium presents data on CD6 on T Cells with Itolizumab. |
|
|
Jun 10, 2021 |
201 |
| First Clinical Trial Application Authorization Received in the EU for its Phase 2 Study of NT-I7 and Opdivo. |
|
|
Jun 10, 2021 |
338 |
| Olivia-Grace to start new treatment. |
JOANNE WELFORD joanne.welford@reachplc.com @joannewelford |
|
Jun 9, 2021 |
538 |
| Adaptive Biotechnologies publishes data on COVID-19 vaccine, T-Cell response. |
|
|
Jun 9, 2021 |
202 |
| LATEST COMPANY NEWS. |
|
|
Jun 8, 2021 |
14128 |
| Mustang Bio to host KOL webinar on MB-106 CD20-targeted CAR T. |
|
|
Jun 7, 2021 |
198 |
| Hookipa Pharma reports 'positive' Phase 1 data from study of HB-200. |
|
|
Jun 7, 2021 |
213 |
| Kite says Tecartus shows high response rate in adults in Phase 1/2 study. |
|
|
Jun 4, 2021 |
398 |
| Precision BioSciences provides update on PBCAR0191 study, PBCAR19B data. |
|
|
Jun 4, 2021 |
372 |
| Harpoon Therapeutics presents updated data for phase 1/2a trial for HPN424. |
|
|
Jun 4, 2021 |
411 |
| Achilles Therapeutics presents phase I/IIa clinical trial design of CHIRON. |
|
|
Jun 4, 2021 |
190 |
| G1 Therapeutics presents data on phase 2 trial on COSELA. |
|
|
Jun 4, 2021 |
295 |
| Selecta announcer paper on hepatic tolerogenic potential of ImmTOR. |
|
|
Jun 1, 2021 |
193 |
| Software package enables deeper understanding of cancer immune responses. |
|
|
Jun 1, 2021 |
184 |
| A Primer on Chimeric Antigen Receptor T-cell Therapy: What Does It Mean for Pathologists? |
Cushman-Vokoun, Allison M.; Voelkerding, Karl V.; Fung, Mark K.; Nowak, Jan A.; Thorson, John A.; Du |
Report |
Jun 1, 2021 |
10823 |
| The occurrence of varicella after zoster vaccination in a patient with rheumatoid arthritis receiving tofacitinib. |
Kao, Chung-Mao; Hsieh, Tsu-Yi; Lai, Kuo-Lung |
Letter to the editor |
Jun 1, 2021 |
912 |
| Blood cancer patients can fight Covid with T cells: Study. |
|
|
May 29, 2021 |
345 |
| Imugene believes it has found "the holy grail of cancer therapy". |
|
|
May 29, 2021 |
698 |
| Imugene believes it has found "the holy grail of cancer therapy". |
|
|
May 29, 2021 |
698 |
| Blood cancer patients can fight Covid with T cells: Study. |
|
|
May 29, 2021 |
345 |
| Chimeric Therapeutics initiates second dose cohort in chlorotoxin CAR T cell phase 1 trial. |
|
|
May 25, 2021 |
330 |
| Chimeric Therapeutics initiates second dose cohort in chlorotoxin CAR T cell phase 1 trial. |
|
|
May 25, 2021 |
330 |
| Janssen Posts Updated Phase 1 Results for Teclistamab Suggesting Deep, Durable Responses in Patients with Heavily Pretreated Multiple Myeloma. |
|
|
May 25, 2021 |
639 |
| ImmunityBio expands COVID-19 vaccine candidate trials. |
|
|
May 25, 2021 |
307 |
| Imugene licenses CD19 Oncolytic virus from City of Hope to turn CAR T therapy against solid tumours. |
|
|
May 19, 2021 |
655 |
| Imugene licenses CD19 Oncolytic virus from City of Hope to turn CAR T therapy against solid tumours. |
|
|
May 19, 2021 |
655 |
| Mustang Bio, City of Hope dose first patient in Phase 1 trial of MB-101. |
|
|
May 18, 2021 |
180 |
| Oxford Immunotec's T-SPOT.COVID Test used in COVID-19 Human Challenge Study. |
|
|
May 18, 2021 |
328 |
| Soligenix reports Q1 EPS (6c), consensus (45c). |
|
Financial report |
May 17, 2021 |
234 |
| Gracell reports Q1 EPS (5c), consensus (21c). |
|
Financial report |
May 17, 2021 |
366 |
| Rubius Therapeutics announces publication of RTX-321 preclinical data. |
|
|
May 12, 2021 |
182 |
| Tevogen Bio's TVGN-489 Allogeneic SARS-CoV-2 Specific Cytotoxic T Cell Therapy Demonstrates Strong Anti-Viral Activity in Preclinical Study. |
|
|
May 11, 2021 |
557 |
| Soligenix's HyBryte awarded Innovation Passport in the U.K. |
|
|
May 10, 2021 |
160 |
| BioVaxys increases patent portfolio and submits commercial trademark application for CoviDTH test. |
|
|
May 3, 2021 |
176 |
| BioVaxys increases patent portfolio and submits commercial trademark application for CoviDTH test. |
|
|
May 3, 2021 |
175 |
| Cabaletta Bio announces pipeline highlights. |
|
|
May 3, 2021 |
170 |
| Developmental Origins of Delayed Adult Immune Response: The AhR Connection. |
Pascual, Florencia |
|
May 1, 2021 |
1008 |
| Recent Advances in Digestive Tract Tumors: Updates From the 5th Edition of the World Health Organization "Blue Book". |
Gonzalez, Raul S.; Raza, Anwar; Propst, Robert; Adeyi, Oyedele; Bateman, Justin; Sopha, Sabrina C.; |
Report |
May 1, 2021 |
14111 |
| Episomal reprogramming of Duchenne muscular dystrophy patients derived CD3+ T cells towards induced pluripotent stem cells. |
Mehwish Zehravi, Mohsin Wahid and Junaid Ashraf |
|
Apr 30, 2021 |
2936 |
| Xencor Doses First Subject in Phase 1 Study of XmAb564, an Engineered IL-2 Cytokine in Development for Autoimmune Diseases. |
|
|
Apr 29, 2021 |
336 |
| PerkinElmer's Oxford Immunotec announce T-SPOT COVID-19 kit used in DIRECT study. |
|
|
Apr 29, 2021 |
189 |
| Oxford Immunotec's T-SPOT Discovery SARS-CoV-2 test used in UK Com-COV trial. |
|
|
Apr 27, 2021 |
415 |
| Marker Therapeutics to present mTAA-specific T cell manufacturing data. |
|
|
Apr 27, 2021 |
167 |
| Vaxart to host KOL webinar on T-Cell responses for COVID-19 vaccines. |
|
|
Apr 26, 2021 |
189 |
| Chimeric Therapeutics progresses to second dosing level with first patient cohort in CLTX CAR T Phase 1 trial. |
|
|
Apr 23, 2021 |
282 |
| Chimeric Therapeutics progresses to second dosing level with first patient cohort in CLTX CAR T Phase 1 trial. |
|
|
Apr 23, 2021 |
282 |
| US FDA Accepts Shorla Pharma Application for its SH-111 Oncology Drug Designed to Treat T-Cell Leukemia. |
|
|
Apr 23, 2021 |
296 |
| Codiak announces publication of data on exoSTING preclinical development. |
|
|
Apr 22, 2021 |
272 |
| Janux Therapeutics Raises USD 125m in Series B Financing. |
|
|
Apr 21, 2021 |
385 |
| Evaxion Biotech presents paper on deep data on immune complex stability. |
|
|
Apr 20, 2021 |
325 |
| Allogene Therapeutics receives IND clearance for ALLO-605. |
|
|
Apr 19, 2021 |
185 |
| Therapeutic Role of Phytochemicals in the Prevention of Oral Potentially Malignant Disorders and Oral Cancer--A Review. |
Nagi, Ravleen; Rakesh, N.; Reddy, Sujatha S.; Konidena, Aravinda; Makkad, Ramanpal Singh; Vyas, Taru |
|
Apr 19, 2021 |
5959 |
| INOVIO's INO-4800 induced neutralizing antibodies and T cell responses against UK, South African and Brazilian COVID-19 variant strains. |
|
|
Apr 16, 2021 |
274 |
| INOVIO's INO-4800 induced neutralizing antibodies and T cell responses against UK, South African and Brazilian COVID-19 variant strains. |
|
|
Apr 16, 2021 |
275 |
| Inovio's COVID-19 vaccine candidate shows response against all tested variants. |
|
|
Apr 15, 2021 |
234 |
| Tevogen Bio to announce encouraging preclinical data of TVGN-489 for COVID-19 at the 2021 Annual Meeting of American Association of Immunologists. |
|
|
Apr 13, 2021 |
174 |
| Tevogen Bio to announce encouraging preclinical data of TVGN-489 for COVID-19 at the 2021 Annual Meeting of American Association of Immunologists. |
|
|
Apr 13, 2021 |
175 |
| Achilles presents patient case study from ongoing Phase I/IIa THETIS trial. |
|
|
Apr 11, 2021 |
203 |
| Harpoon Therapeutics announces data from poster presentations at AACR meeting. |
|
|
Apr 11, 2021 |
313 |
| Hookipa announces preliminary Phase 1 immunogenicity data for HB-201, HB-202. |
|
|
Apr 11, 2021 |
515 |
| Crispr Therapeutics presents preclinical data on CD70 Knockout. |
|
|
Apr 11, 2021 |
226 |
| F-star Therapeutics shows differentiation of FS222 in 2021 AACR Poster. |
|
|
Apr 11, 2021 |
322 |
| GOSH... JOSH IS A MIRACLE; Leukaemia boy's incredible recovery. |
EXCLUSIVE by Fiona Duffy |
|
Apr 11, 2021 |
477 |
| SQZ presents preclinical data on mRNA-based eAPCs, potential applicability. |
|
|
Apr 11, 2021 |
374 |
| Xencor presents data from preclinical XmAb Bispecific antibody/cytokine programs. |
|
|
Apr 11, 2021 |
671 |
| NextCure presents preclinical data for NC762 at AACR Annual Meeting. |
|
|
Apr 11, 2021 |
153 |
| ImmunityBio Says Single Prime hAd5 COVID-19 Vaccination Induces a 10-Fold Increase in T Cell Response Equivalent to T Cell Responses from Patients Previously Infected with SARS-CoV-2. |
|
|
Apr 9, 2021 |
818 |
| ChemoCentryx announces poster presentation on CCX559. |
|
|
Apr 9, 2021 |
194 |
| Sana Biotechnology presents preclinical data from T cell programs. |
|
|
Apr 9, 2021 |
297 |
| ImmunityBio says single prime hAd5 COVID-19 vaccination induces T-cell responses. |
|
Clinical report |
Apr 8, 2021 |
285 |
| Bioniz Therapeutics' BNZ-1 receives European Commission orphan designation. |
|
|
Apr 7, 2021 |
170 |
| Bioniz Therapeutics' BNZ-1 receives European Commission orphan designation. |
|
|
Apr 7, 2021 |
171 |
| CTL Mourns Odumakin, Says He Left A Huge Vacuum. |
|
|
Apr 4, 2021 |
323 |
| Relapse of T-Cell Lymphoma as Isolated Brachial Plexus Neurolymphomatosis: A Case Report. |
Kibici, Kenan; Erok, Berrin; Atca, Ali Onder; Yegen, Gulcin |
Clinical report |
Apr 1, 2021 |
1679 |
| The Retrospective Analysis of Patients Diagnosed with T-Cell Lymphoma at BezmialemVakif University's School of Medicine Hospital. |
Balci, Ece; Cetin, Guven |
Report |
Apr 1, 2021 |
357 |
| UK-based Achilles Therapeutics unveils US$175.5mln IPO at Nasdaq debut. |
|
|
Apr 1, 2021 |
193 |
| UK-based Achilles Therapeutics unveils US$175.5mln IPO at Nasdaq debut. |
|
|
Apr 1, 2021 |
193 |
| Tiziana Life Sciences plans phase II trials of nasal antibody treatment in COVID-19 patients. |
|
|
Mar 31, 2021 |
241 |
| Tiziana Life Sciences plans phase II trials of nasal antibody treatment in COVID-19 patients. |
|
|
Mar 31, 2021 |
241 |
| New US study finds T cells induced by COVID-19 infection respond to COVID-19 virus variants. |
|
Report |
Mar 31, 2021 |
252 |
| New US study finds T cells induced by COVID-19 infection respond to COVID-19 virus variants. |
|
Report |
Mar 31, 2021 |
251 |
| ONE PFIZER DOSE 'BOOSTS IMMUNITY'. |
|
|
Mar 30, 2021 |
234 |
| Equillium announces data from Equalise study in patients with SLE. |
|
Report |
Mar 30, 2021 |
173 |
| Vaccine study's positive results; 99% SHOWING ROBUST RESPONSE FROM A DOSE. |
MIKE KELLY Reporter mike.kelly@ncjmedia.co.uk |
|
Mar 29, 2021 |
401 |
| ImmunityBio Reports 12-Month Overall Survival Probability of 83% in NCI-Led Phase 1 Study of Multi-Targeted hAd5 Immunotherapy Vaccine in Patients with Advanced Metastatic Prostate Cancer. |
|
|
Mar 29, 2021 |
463 |
| ImmunityBio announces results of multi-targeted Immunotherapy vaccine study. |
|
|
Mar 29, 2021 |
205 |
| Avalon GloboCare, University of Pittsburgh enter collaboration. |
|
|
Mar 29, 2021 |
302 |
| US Food and Drug Administration Approves Bristol Myers Squibb's and Bluebird Bio's Abecma for Relapsed or Refractory Multiple Myeloma. |
|
|
Mar 29, 2021 |
815 |
| FDA approves Bristol Myers Squibb, Bluebird Bio's Abecma. |
|
|
Mar 28, 2021 |
263 |
| Maxcyte: At the forefront of cell therapy revolution. |
|
|
Mar 25, 2021 |
503 |
| Step Pharma Raises EUR 35m in series B Financing to Advance First in Class CTPS1 inhibitor into the Clinic in T Cell Malignancies. |
|
|
Mar 25, 2021 |
364 |
| Sarah is first patient to trial new cancer treatment offering hope. |
LISA O'BRIEN lisa.obrien@mnamedia.co.uk |
|
Mar 25, 2021 |
465 |
| Actinium Pharmaceuticals begins patient enrollment in Iomab-ACT trial. |
|
|
Mar 24, 2021 |
193 |
| Mustang Bio reports FY20 EPS ($1.14), consensus ($1.01). |
|
Financial report |
Mar 24, 2021 |
186 |
| ONK Therapeutics Licenses EBV-LCL Feeder Cell Line from NIH to Enhance NK Cell Expansion. |
|
|
Mar 22, 2021 |
565 |
| ImmunityBio announces preclinical data on efficacy of PD-L1 t-haNK therapy. |
|
|
Mar 22, 2021 |
278 |
| Chimeric Therapeutics has strong bank balance to progress ground-breaking CAR-T cell therapies for solid tumours. |
|
|
Mar 20, 2021 |
947 |
| Chimeric Therapeutics doses first patient cohort for Phase 1 CLTX CAR T trial. |
|
|
Mar 19, 2021 |
347 |
| T-Cure Bioscience Enters Agreement with Rutgers to Conduct Clinical Research of Novel T Cell Receptor Therapy for Treatment of Variety of Cancers. |
|
|
Mar 17, 2021 |
313 |
| An open-label randomized clinical trial to evaluate the efficacy of everolimus versus tacrolimus in triple maintenance immunosuppressive therapy for kidney transplant patients. |
Assis, B.P.S.; Lasmar, M.F.; Fabreti-Oliveira, R.A.; Araujo, S.A.; Oliveira, J.; Wanderley, D.C.; Na |
|
Mar 17, 2021 |
5087 |
| Tevogen Bio Forges Partnership with BioCentriq, New Jersey Innovation Institute's Cell and Gene Therapy Center, to Enhance Tevogen's Development Capacity of Its Proprietary Targeted T Cell Therapy For COVID-19. |
|
|
Mar 16, 2021 |
249 |
| ImmunityBio Touts Positive Interim Phase I Safety Data of hAd5 T-Cell COVID-19 Vaccine Candidate in Oral and Sublingual Formulations. |
|
|
Mar 16, 2021 |
347 |
| Scancell focuses on cancer immunotherapies and COVID-19 vaccine. |
|
|
Mar 16, 2021 |
498 |
| Ewan wins battle in time for his 18th; young guitarist beat tumour on his spine to be an 'inspiration'. |
ROBERT SUTCLIFFE robert.sutcliffe@trinitymirror.com @MRRSUTCLIFFE |
|
Mar 9, 2021 |
483 |
| ImmunityBio, NantKwest Begin Dosing Participants in Global Trials for Novel COVID-19 Vaccine. |
|
|
Mar 9, 2021 |
703 |
| Gilead T-cell therapy gets US backing as third line cancer treatment. |
|
|
Mar 8, 2021 |
166 |
| ISA Pharmaceuticals selects ISA106 COVID-19 immunotherapy for clinical trial. |
|
|
Mar 3, 2021 |
203 |
| ISA Pharmaceuticals selects ISA106 COVID-19 immunotherapy for clinical trial. |
|
|
Mar 3, 2021 |
202 |
| EVEREST SUPPORTS USA CLAY TARGET LEAGUE. |
|
|
Mar 1, 2021 |
286 |
| T cells mount attacks against many SARS-CoV-2 targets. |
|
|
Mar 1, 2021 |
355 |
| High Prevalence of Anemia among Human Immunodeficiency Virus-Infected Patients: A Cross-sectional Study in Bali-Indonesia. |
Aryastuti, Sri Agung; Dewi, SriRatna; Masyeni, Sri |
Report |
Mar 1, 2021 |
2969 |
| Central Role of T Follicular Helper Cells in Myasthenia Gravis. |
Wu, Na; Tuzun, Erdem; Cheng, Yi; Yan, Li; Wu, Yajun; Huang, Hui; Li, Siyu; Shi, Ling; Wu, Xiaorong |
|
Mar 1, 2021 |
5365 |
| Innate and Th1/Th17 adaptive immunity in acute and convalescent Brazilian borreliosis disease. |
Bonoldi, Virginia Lucia Nazario; Yoshinari, Natalino Hajime; de Aniz, Patricia Antonia Estima Abreu; |
Report |
Mar 1, 2021 |
5224 |
| Effects of paternal lymphocyte immunization in women with unexplained infertility. |
Murni, Nani; Mansur, Indra Gusti; Rachman, Ichramsyah A.; Sadikin, Mohamad |
Report |
Feb 28, 2021 |
2061 |
| Sub-genomic analysis of Chikungunya virus E2 mutations in Pakistani isolates potentially modulating B-cell and T-Cell immune response. |
Bilal Ahmed Khan, Saifullah, Amanullah Lail and Saeed Khan |
|
Feb 24, 2021 |
3015 |
| Covid vaccines: We have been extremely lucky but may not be when the next pandemic strikes - Professor Eleanor Riley; Given the speed at which the global scientific community has developed at least six highly effective vaccines to combat a pandemic virus that was completely unknown barely a year ago, you might be forgiven for thinking that making vaccines is really easy. It isn't, or not always. |
Eleanor Riley |
|
Feb 22, 2021 |
618 |
| First Patient Dosed in Phase 2 Study of NT-I7 and Opdivo. |
|
Report |
Feb 17, 2021 |
335 |
| ImmunityBio partners with NantKwest to study hAd5 T-Cell COVID-19 Vaccine. |
|
|
Feb 12, 2021 |
285 |
| ImmunityBio partners with NantKwest to study hAd5 T-Cell COVID-19 Vaccine. |
|
|
Feb 12, 2021 |
289 |
| Tmunity Therapeutics Expands T Cell Engineered Therapy Collaboration. |
|
|
Feb 10, 2021 |
410 |
| FDA Approves New Treatment for Adults with Relapsed or Refractory Large-B-Cell Lymphoma. |
|
|
Feb 8, 2021 |
618 |
| US FDA approves Juno Therapeutics' Breyanzi to treat adults with relapsed or refractory large-B-Cell Lymphoma. |
|
|
Feb 8, 2021 |
187 |
| US FDA approves Juno Therapeutics' Breyanzi to treat adults with relapsed or refractory large-B-Cell Lymphoma. |
|
|
Feb 8, 2021 |
183 |
| Immune Checkpoint Inhibitor-Induced Upper Gastrointestinal Tract Inflammation Shows Morphologic Similarities to, but Is Immunologically Distinct From, Helicobacter pylori Gastritis and Celiac Disease. |
Irshaid, Lina; Robert, Marie E.; Zhang, Xuchen |
Report |
Feb 1, 2021 |
6049 |
| Evaluation of Positive B- and T-Cell Gene Rearrangement Studies in Patients With Negative Morphology, Flow Cytometry, and Immunohistochemistry. |
Mendoza, Hadrian; Tormey, Christopher A.; Siddon, Alexa J. |
Report |
Feb 1, 2021 |
3106 |
| BCMA CAR-T Therapy Cilta-cel Accepted for Accelerated Assessment in Europe for the Treatment of Relapsed and/or Refractory Multiple Myeloma. |
|
|
Feb 1, 2021 |
485 |
| Teenager who beat cancer three times dies in parent's arms after catching Covid; Aspen Deke, 17, had struggled for most of her life with acute lymphoblastic leukemia, enduring both a a bone marrow transplant and CAR-T cell immunotherapy. |
By, William Walker |
|
Feb 1, 2021 |
397 |
| MYCOSIS FUNGOIDES: Workup includes multiple biopsies. |
Jancin, Bruce |
|
Feb 1, 2021 |
1176 |
| Tevogen Bio supports clinical trials of investigational curative T cell therapy for COVID-19 under HMP Partners funding. |
|
|
Jan 26, 2021 |
227 |
| Tevogen Bio supports clinical trials of investigational curative T cell therapy for COVID-19 under HMP Partners funding. |
|
|
Jan 26, 2021 |
223 |
| TScan Therapeutics Raises USD 100m in Series C Financing. |
|
|
Jan 26, 2021 |
327 |
| TOP NEWS: Glaxo And Merck KGaA Discontinue Bintrafusp Alfa Trial. |
|
|
Jan 20, 2021 |
246 |
| Faron Notes "Remarkable" Observations From Bexmarilimab Trial. |
|
|
Jan 20, 2021 |
327 |
| Euroimmun Launches SARS-CoV-2 Test System to Detect T-Cell Response. |
|
|
Jan 14, 2021 |
245 |
| KSQ Therapeutics and Takeda Forge Collaboration to Research, Develop and Commercialize Novel Immuno-Oncology Therapies. |
|
|
Jan 13, 2021 |
307 |
| MaxCyte inks licensing deal with Myeloid Therapeutics to advance cancer therapies. |
|
|
Jan 12, 2021 |
310 |
| Arix Bioscience portfolio firms Autolus and Imara issue updates. |
|
|
Jan 7, 2021 |
842 |
| ImaginAb signs license and supply agreement for CD8 ImmunoPET Technology with Pfizer. |
|
|
Jan 7, 2021 |
197 |
| ImaginAb signs license and supply agreement for CD8 ImmunoPET Technology with Pfizer. |
|
|
Jan 7, 2021 |
193 |
| EpiVax, EpiVax Therapeutics Advance EPV-CoV-19 COVID-19 Vaccine Programme. |
|
|
Jan 4, 2021 |
357 |
| EpiVax reveals details on progress of peptide-based COVID-19 vaccine. |
|
|
Jan 4, 2021 |
243 |
| EpiVax reveals details on progress of peptide-based COVID-19 vaccine. |
|
|
Jan 4, 2021 |
239 |
| Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France. |
Gallais, Floriane; Velay, Aurelie; Nazon, Charlotte; Wendling, Marie-Josee; Partisani, Marialuisa; S |
Report |
Jan 1, 2021 |
5149 |
| Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2-Specific IgG. |
Schwarzkopf, Sina; Krawczyk, Adalbert; Knop, Dietmar; Klump, Hannes; Heinold, Andreas; Heinemann, Fa |
Report |
Jan 1, 2021 |
5801 |
| Placental Morphology and Cellular Characteristics in Stillbirths in Women With Diabetes and Unexplained Stillbirths. |
Kerby, Alan; Shingleton, Daniel; Batra, Gauri; Sharps, Megan C.; Baker, Bernadette C.; Heazell, Alex |
Report |
Jan 1, 2021 |
5923 |
| Achieving better outcomes for predictive analytics. |
Winkenbach, Matthias |
|
Jan 1, 2021 |
1343 |
| DNA Methylation Patterns in [CD4.sup.+] T Cells of Naive and Influenza A Virus-Infected Mice Developmentally Exposed to an Aryl Hydrocarbon Receptor Ligand. |
Burke, Catherine G.; Myers, Jason R.; Post, Christina M.; Boule, Lisbeth A.; Lawrence, B. Paige |
Report |
Jan 1, 2021 |
16242 |
| A case of statin-associated immune-mediated necrotizing myopathy with atypical biopsy features. |
Zaki, Mark M.; Virk, Zain M.; Lopez, Diego; Klubnick, Jenna; Ahrendsen, Jared T.; Varma, Hemant; Kyt |
Clinical report |
Jan 1, 2021 |
3317 |
| ENDOTHELIAL PROTEIN C RECEPTOR EXPRESSION IS REGULATED BY SP1 TRANSCRIPTION FACTOR IN MURINE MICROGLIA. |
Tufekci, Kemal Ugur; Ates, Halil; Genc, Sermin |
|
Jan 1, 2021 |
4034 |
| A clinical study of mucocutaneous manifestation of HIV/AIDs and its correlation with CD4 count. |
Niya Khat, Chandramohan Kudligi, Ravi Munasingh Rathod, Vidya Kuntoji, Pradeep Vittal Bhagwat, Sanja |
Clinical report |
Dec 31, 2020 |
3556 |
| Frequency of undiagnosed HIV infection in patients of seborrheic dermatitis. |
Zaib, Khalida Ahtesham, Tahira Tabassum, Anam Ilyas, Sara Inayat, Zaeem Sohail Jafer and Ahmad Amin |
|
Dec 31, 2020 |
1724 |
| Clinical and Laboratory Characteristics of Primary Immunodeficiency Patients from a Tertiary Care Center in Pakistan. |
Tipu, Hamid Nawaz; Ahmed, Dawood |
Report |
Dec 31, 2020 |
3709 |
| Humanigen wins US patent for Lenzilumab in preventing cytokine storm and neurotoxicity related to CAR-T cell therapy. |
|
|
Dec 29, 2020 |
363 |
| IMV Provides Update on COVID-19 Vaccine Program. |
|
|
Dec 28, 2020 |
586 |
| Humanigen Secures US Patent for Lenzilumab in Preventing Cytokine Storm and Neurotoxicity Related to CAR-T Cell Therapy. |
|
|
Dec 28, 2020 |
375 |
| Even mild Covid-19 cases may provide lasting immunity, shows study. |
|
|
Dec 25, 2020 |
511 |
| Legend Biotech Initiates Rolling Submission of Biologics License Application to US FDA Seeking Approval of BCMA CAR-T Therapy Cilta-cel for the Treatment of Relapsed and/or Refractory Multiple Myeloma. |
|
|
Dec 22, 2020 |
659 |
| Jessner's Lymphocytic Infiltrate--A Rare Case Report. |
Mishra, Preeti; Vagha, Sunita; Hiwale, Keshav; Shukla, Samarth |
|
Dec 21, 2020 |
1270 |
| Janux Therapeutics partners with Merck to develop novel drug candidates for immuno oncology using TRACTr Technology. |
|
|
Dec 21, 2020 |
213 |
| Janux Therapeutics partners with Merck to develop novel drug candidates for immuno oncology using TRACTr Technology. |
|
|
Dec 21, 2020 |
209 |
| Janux Therapeutics Forges Collaboration with Merck to Develop Novel Drug Candidates for Immuno-Oncology Using T Cell Engager (TRACTr) Technology. |
|
|
Dec 21, 2020 |
372 |
| Scancell Holdings chooses candidate for coronavirus vaccine. |
|
|
Dec 19, 2020 |
346 |
| There's more to Covid immunity than antibodies; 2 MINUTES ON... |
DR MIRIAM STOPPARD |
|
Dec 18, 2020 |
153 |
| There's more to Covid immunity than antibodies; DMUULS 42 DAILY MIRROR FRIDAY 18.12.2020 Dr Miriam Stoppard MINUTES ON... |
Dr Miriam Stoppard |
|
Dec 18, 2020 |
153 |
| Scancell Shares Rise As It Chooses Vaccine Candidate For Development. |
|
|
Dec 18, 2020 |
207 |
| A RAPID RESPONSE VACCINE DEVELOPMENT STRATEGY FOR NEWCASTLE DISEASE IN POULTRY. |
Maremagae, S.R.; Bezuidenhout, C.C.; Murphy, A.M.; Jarvis, M.A.; Naicker, P.; Lebea, P.J. |
Report |
Dec 15, 2020 |
4741 |
| ImmunityBio's hAd5 T-Cell COVID-19 Vaccine Candidate Shows Complete Protection of Airways in Non-Human Primates. |
|
|
Dec 10, 2020 |
744 |
| Newspaper executive from Grayslake championed industry's causes Kramer: Memorial service will be held in Gurnee. |
Christopher Placek cplacek@dailyherald.com |
|
Dec 9, 2020 |
523 |
| Bayer & Atara Biotherapeutics partnership leverage mesothelin-targeted CAR T-cell therapies for solid tumors. |
|
|
Dec 7, 2020 |
296 |
| Bayer & Atara Biotherapeutics partnership leverage mesothelin-targeted CAR T-cell therapies for solid tumors. |
|
|
Dec 7, 2020 |
300 |
| Bayer, Atara Biotherapeutics Team To Develop Solid Tumour Therapies. |
|
|
Dec 7, 2020 |
265 |
| Preclinical Data Demonstrate Anti-Viral Activity of AlloVir's ALVR109, an Allogeneic, Off-the-Shelf SARS-CoV-2 Specific T Cell Therapy. |
|
|
Dec 7, 2020 |
443 |
| Role of Th2 type Cytokines and IgE in Asthmatic Children. |
Abo-Shanab, Assem Metwally; Elnady, Hala; Helwa, Iman; Abdelkawy, Rania Fawzy Mahmoud; Atta, Hanan; |
Report |
Dec 1, 2020 |
4466 |
| Role Of T Cells In MS. |
|
|
Dec 1, 2020 |
281 |
| Boosting Stem Cell Activity Can Enhance Immunotherapy Benefits. |
|
|
Nov 30, 2020 |
155 |
| Cancer Patient Treated With Stem Cell Transplant Later Develops Retinal Condition. |
|
|
Nov 16, 2020 |
446 |
| Maxcyte: At the forefront of cell therapy revolution. |
|
|
Nov 14, 2020 |
729 |
| TScan Therapeutics Forges Partnership with Qiagen to Develop T Cell-Based Laboratory Test for Comprehensive COVID-19 Immune Response. |
|
|
Nov 11, 2020 |
423 |
| Vor Biopharma Gains Exclusive License of Clinical-Stage CD33 CAR-T from National Cancer Institute. |
|
|
Nov 11, 2020 |
403 |
| Oxford Biomedica clinches CAR-T cell therapies collaboration with PhoreMost. |
|
|
Nov 10, 2020 |
246 |
| ImmunityBio's hAd5 COVID-19 Vaccine Candidate Stimulates Memory T-Cell Recall in Patients Infected with SARS-CoV-2. |
|
|
Nov 9, 2020 |
525 |
| ImmunityBio declares positive study results for human Ad5 (hAd5) COVID-19 vaccine candidate. |
|
|
Nov 9, 2020 |
240 |
| ImmunityBio declares positive study results for human Ad5 (hAd5) COVID-19 vaccine candidate. |
|
|
Nov 9, 2020 |
236 |
| Oxford BioMedica, PhoreMost Team For Next-Gen Cell Therapy Development. |
|
|
Nov 9, 2020 |
185 |
| Immunity stronger in those who had symptoms. |
|
|
Nov 5, 2020 |
281 |
| Humanigen to present abstract covering a lymphoma study of its drug lenzilumab at hematology conference. |
|
Conference news |
Nov 5, 2020 |
303 |
| NA Proactive news snapshot: Humanigen, Metalla Royalty & Streaming, DGTL Holdings, Tetra Bio-Pharma UPDATE ... |
|
|
Nov 5, 2020 |
2204 |
| First Patient Dosed with Camidanlumab Tesirine in Combination with Pembrolizumab in Ongoing Phase 1b Clinical Trial in Selected Solid Tumors. |
|
|
Nov 4, 2020 |
614 |
| University study reveals six-month 'cellular immunity' from Covid-19. |
|
|
Nov 3, 2020 |
213 |
| T-cell study adds to debate over duration of Covid-19 immunity. |
Reuters News Service |
|
Nov 2, 2020 |
416 |
| Study Using Stem Cell-Based Crohn's Treatment Begins At Cleveland Clinic. |
|
Clinical report |
Nov 2, 2020 |
261 |
| Cold autoimmune haemolytic anaemia as the presenting feature in a patient with angioimmunoblastic T-cell lymphoma an illustrative case. |
Gates, Shirley May; Lombard, Elizabeth |
|
Nov 1, 2020 |
2627 |
| Unveiling the Immunomodulatory Characteristics of Haemonchus contortus Ephrin Domain Containing Protein in the Parasite-Host Interactions. |
Aimulajiang, Kalibixiati; Wen, Zhaohai; Tian, Xiaowei; Lakho, Shakeel Ahmed; Zhang, Yang; Naqvi, Muh |
|
Nov 1, 2020 |
6891 |
| PeproMene Bio submits US FDA Investigational New Drug application to study PMB-101. |
|
|
Oct 29, 2020 |
214 |
| PeproMene Bio submits US FDA Investigational New Drug application to study PMB-101. |
|
|
Oct 29, 2020 |
210 |
| Immatics presents preclinical PoC data for IMA401. |
|
|
Oct 29, 2020 |
316 |
| Bellicum Pharmaceuticals says BPX-601 trial did not observe clinical efficacy. |
|
|
Oct 29, 2020 |
186 |
| Rubius Therapeutics presents new preclinical RTX-321 data at FOCIS meeting. |
|
|
Oct 28, 2020 |
333 |
| Compugen to present data on potential of PVRIG in cancer inmunotherapy. |
|
|
Oct 27, 2020 |
175 |
| Daiichi Sankyo doses first patient in cancer drug DS-1055 study. |
|
|
Oct 23, 2020 |
194 |
| Daiichi Sankyo doses first patient in cancer drug DS-1055 study. |
|
|
Oct 23, 2020 |
198 |
| CureVac announces data from preclinical SARS-CoV-2 vaccine candidate studies. |
|
|
Oct 23, 2020 |
427 |
| UK's Vaccine Taskforce partners with Oxford Immunotech to assess COVID-19 vaccine T cell responses. |
|
|
Oct 22, 2020 |
186 |
| UK's Vaccine Taskforce partners with Oxford Immunotech to assess COVID-19 vaccine T cell responses. |
|
|
Oct 22, 2020 |
190 |
| Soligenix's SGX301 shows improved response in Phase 3 T-cell lymphoma study. |
|
|
Oct 22, 2020 |
174 |
| Actinium Pharmaceuticals awarded grant by NIH to study Iomab-ACT. |
|
|
Oct 21, 2020 |
177 |
| Crispr Therapeutics reports top-line results from Phase 1 CARBON trial of CTX110. |
|
|
Oct 21, 2020 |
527 |
| First Patient Dosed in Phase 1 Clinical Trial of Second-Generation COVID-19 Vaccine Candidate Delivering Both Spike and Nucleocapsid of SARS-CoV-2. |
|
|
Oct 21, 2020 |
1017 |
| European CHMP Adopts Positive Opinion for Kite's KTE-X19 for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma. |
|
|
Oct 20, 2020 |
523 |
| Boehringer Ingelheim, Oxford BioTherapeutics Expand Collaboration to Discover Novel Selective Tumor Targets as First Bispecific Antibody Advanced into the Clinic. |
|
|
Oct 19, 2020 |
333 |
| Minor Changes In Immune Cells Have Major Effect On Immune Response. |
|
|
Oct 19, 2020 |
686 |
| FDA Authorizes Phase 1 Trial of ImmunityBio's Novel COVID-19 Vaccine Candidate hAd5. |
|
|
Oct 16, 2020 |
483 |
| OncoPep Strengthens Pipeline with Addition of Multi-Tumor Antigen Adoptive T Cell Therapy. |
|
|
Oct 15, 2020 |
356 |
| Tevogen Bio submits clinical trials of T Cell IND with FDA to develop treatment for COVID-19. |
|
|
Oct 15, 2020 |
189 |
| Tevogen Bio Submits IND Submitted to FDA for Clinical Trials of T Cell Treatment for COVID-19. |
|
|
Oct 15, 2020 |
355 |
| Tevogen Bio submits Investigational New Drug application for COVID-19 treatment development. |
|
|
Oct 15, 2020 |
167 |
| Tevogen Bio submits clinical trials of T Cell IND with FDA to develop treatment for COVID-19. |
|
|
Oct 15, 2020 |
193 |
| Tevogen Bio submits Investigational New Drug application for COVID-19 treatment development. |
|
|
Oct 15, 2020 |
171 |
| NantKwest affiliate ImmunityBio gets FDA approval for hAd5-COVID-19 trial. |
|
|
Oct 15, 2020 |
188 |
| Precision BioSciences says U.S. PTAB upholds allogeneic CAR T patents. |
|
|
Oct 15, 2020 |
271 |
| MacroGenics announces publication of flotetuzumab data. |
|
|
Oct 15, 2020 |
262 |
| Scancell focuses on cancer immunotherapies and COVID-19 vaccine. |
|
|
Oct 13, 2020 |
529 |
| Twist Bioscience, Neogene announce strategic partnership for T cell therapies. |
|
|
Oct 13, 2020 |
216 |
| Axis Therapeutics, a n Athenex and XLifeSc JV, in pact with h PharmaEssentia. |
|
|
Oct 12, 2020 |
217 |
| Vir Biotechnology announces publication of research on monoclonal antibodies. |
|
|
Oct 9, 2020 |
274 |
| NEC OncoImmunity AS, Oslo University Hospital Team Up to Develop a Diagnostic for COVID-19 Using Artificial Intelligence. |
|
|
Oct 9, 2020 |
499 |
| ChromaDex's licensed nicotinamide riboside shows anti-cancer function in study. |
|
|
Oct 8, 2020 |
183 |
| Antibodies fight off the new coronavirus, but what do T cells do? |
|
|
Oct 7, 2020 |
371 |
| Heat Biologics issued new patent for gp96 platform with ICOSL. |
|
|
Oct 7, 2020 |
232 |
| A2 Biotherapeutics Closes USD 71.5m Series B Financing. |
|
|
Oct 7, 2020 |
344 |
| BioNTech, Pfizer initiate rolling submission to EMA for BNT162b2. |
|
|
Oct 6, 2020 |
191 |
| Corvus Pharmaceuticals announces updated data from Phase 1 study of CPI-006. |
|
|
Oct 5, 2020 |
896 |
| Miragen says cobomarsen lacks a 'compelling result' for primary endpoint. |
|
|
Oct 5, 2020 |
236 |
| Christie patient takes on virtual London marathon. |
|
|
Oct 2, 2020 |
212 |
| Avalon expands AVA-001 trial to non-Hodgkin lymphoma patients; plans acute respiratory distress syndrome trial for later this year. |
|
|
Oct 2, 2020 |
436 |
| Mustang Bio doses first patient in Phase 1/2 trial of MB-102. |
|
|
Oct 1, 2020 |
201 |
| Avalon GloboCare provides clinical updates on CAR, MSC programs. |
|
|
Oct 1, 2020 |
443 |
| Determination of B- and T- cell epitopes for Helicobacter pylori cagPAl: An in silico approach. |
Tas, Sevgi Kalkanli; Kirkik, Duygu; Ozturk, Kubra; Tanoglu, Alpaslan |
Report |
Oct 1, 2020 |
4027 |
| Leucocytes and Th-associated Cytokine Profile of HIV-Leishmaniasis Co-Infected Persons Attending Abuja Teaching Hospital, Nigeria. |
Abdullahi, Idris Nasir; Emeribe, Anthony Uchenna; Adekola, Hafeez Aderinsayo; Muhammad, Habiba Yahay |
|
Oct 1, 2020 |
5069 |
| Caerin 1 Antimicrobial Peptides that Inhibit HIV and Neisseria May Spare Protective Lactobacilli. |
Rollins-Smith, Louise A.; Smith, Patricia B.; Ledeczi, Anna M.; Rowe, Julia M.; Reinert, Laura K. |
Report |
Oct 1, 2020 |
5560 |
| Determination of B- and T-cell epitopes for Helicobacter pylori cagPAI: An in silico approach. |
Tas, Sevgi Kalkanli; Kirkik, Duygu; Ozturk, Kubra; Tanoglu, Alpaslan |
|
Oct 1, 2020 |
4247 |
| Maternal Supplementation with Dietary Betaine during Gestation to Improve Twin Lamb Survival. |
Brougham, Billie-Jaye; Weaver, Alice C.; Swinbourne, Alyce M.F.; Baida, Bobbie E. Lewis; Kelly, Jenn |
Report |
Oct 1, 2020 |
8942 |
| HUYA Bioscience receives Japanese orphan drug designation for HBI-8000. |
|
|
Sep 29, 2020 |
163 |
| HUYA Bioscience receives Japanese orphan drug designation for HBI-8000. |
|
|
Sep 29, 2020 |
159 |
